Due to a production error, the incorrect Supplementary Material files were published. The Supplementary Material files have been corrected.
The publisher apologizes for this mistake. The original article has been updated.
. 2021 Oct 21;12:788046. doi: 10.3389/fphar.2021.788046
Erratum: Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies
Frontiers Production Office
1,*
Frontiers Production Office
1Frontiers Media SA, Lausanne, Switzerland
Find articles by Frontiers Production Office
1Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office, pharmacology.production.office@frontiersin.org
This article was submitted to Pharmacology of Ion Channels and Channelopathies, a section of the journal Frontiers in Pharmacology
Received 2021 Oct 1; Accepted 2021 Oct 1; Collection date 2021.
Keywords: PLM, NCX1, disruptor peptide, NKA, cardiac, brain, peptide arrays, peptidomimetics
Copyright © 2021 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC8568046 PMID: 34744755
This corrects the article "Design of a Proteolytically Stable Sodium-Calcium Exchanger 1 Activator Peptide for In Vivo Studies", 638646.